Inactive Instrument

HumanOptics AG

Equities

H9O1

DE000A1MMCR6

Medical Equipment, Supplies & Distribution

Humanoptics Ag Reports Earnings Results for the Half Year Ended December 31, 2020

April 30, 2021 at 12:07 pm EDT

HumanOptics AG announced earnings results for the half year ended December 31, 2020. For the half year, the company announced total revenue was EUR 5.840 million compared to EUR 5.969 million a year ago. Net loss was EUR 133,000 compared to EUR 581,000 a year ago.

Latest news about HumanOptics AG

HumanOptics AG Revises Earnings Guidance for the Fiscal Year 2021	21-05-19	CI
Humanoptics Ag Reports Earnings Results for the Half Year Ended December 31, 2020	21-04-30	CI
Humanoptics Ag Announces Executive Appointments, Effective 15 March 2021	21-01-15	CI
Humanoptics Ag Announces Executive Appointments	21-01-15	CI
HumanOptics AG Revises Earnings Guidance for the Year Ended on 30 June 2020	20-08-27	CI
HumanOptics AG Announces Management Changes	20-04-20	CI
HumanOptics AG Receives Health Insurance Approval for Artificial Iris CUSTOMFLEX Artificialiris	20-01-23	CI
An unknown investor completed the acquisition of 73.4% stake in HumanOptics AG (DB:H9O1) from Medipart AG.	19-12-17	CI
An unknown investor signed a share purchase agreement to acquire 73.4% stake in HumanOptics AG (DB:H9O1) from Medipart AG.	19-08-29	CI
HumanOptics AG Appoints Pierre Billardon as Chief Executive Officer	17-01-10	CI
HumanOptics AG announced that it has received €0.85 million in funding	16-10-19	CI
Medipart AG acquired a majority stake in HumanOptics AG (XTRA: H9O).	12-02-01	CI

Chart HumanOptics AG

Duration

Period

More charts

Company Profile

HumanOptics AG is a Germany-based company that develops, produces and distributes intelligent technology for eye implantation surgery, especially intraocular lenses (IOL). These artificial lenses are implanted into the human eye. Indications for IOL implantations are eye diseases, such as the cataract. Intraocular lenses are also used for refractive surgery to correct refractive errors of the eye causing ametropia. The lenses are distributed under the brand names of Aspira, Diffractiva, Secura and Torica, among others. In addition, the Company offers its target group, the ophthalmic surgeons, accessories and complementary products, as well as consulting services. It operates also a wholly owned subsidiary, Dr. Schmidt Intraocularlinsen GmbH. On February 2, 2012, Medipart AG became majority shareholder of the Company.

Sector

Medical Equipment, Supplies & Distribution

More about the company

Sector Other Medical Equipment, Supplies & Distribution

	1st Jan change	Capi.
ABBOTT LABORATORIES	-2.31%	187B
MEDTRONIC PLC	-3.20%	106B
BECTON, DICKINSON AND COMPANY	-5.04%	66.9B
DEXCOM, INC.	+0.20%	49.45B
CENCORA, INC.	+17.29%	48B
HOYA CORPORATION	+4.06%	40.84B
METTLER-TOLEDO INTERNATIONAL, INC.	+2.07%	26.48B
WEST PHARMACEUTICAL SERVICES, INC.	+2.36%	26.25B
TERUMO CORPORATION	+12.96%	24.62B

Other Medical Equipment, Supplies & Distribution